Publications
Filters: Keyword is Adult [Clear All Filters]
“International gestational age-specific centiles for umbilical artery Doppler indices: a longitudinal prospective cohort study of the INTERGROWTH-21(st) Project”, Am J Obstet Gynecol, vol. 222, no. 6, pp. 602 e1-602 e15, 2020.
, “The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial”, PLoS Med, vol. 16, no. 2, p. e1002745, 2019.
, “Spatiotemporal epidemiology, environmental correlates, and demography of malaria in Tak Province, Thailand (2012-2015)”, Malar J, vol. 18, no. 1, p. 240, 2019.
, “Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study”, Malar J, vol. 17, no. 1, p. 427, 2018.
, “Genotypic and phenotypic characterization of G6PD deficiency in Bengali adults with severe and uncomplicated malaria”, Malar J, vol. 16, no. 1, p. 134, 2017.
, “Use of an Anopheles Salivary Biomarker to Assess Malaria Transmission Risk Along the Thailand-Myanmar Border”, J Infect Dis, vol. 215, no. 3, pp. 396-404, 2017.
, “Dense genomic sampling identifies highways of pneumococcal recombination”, Nat Genet, vol. 46, no. 3, pp. 305-9, 2014.
, “Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda”, J Antimicrob Chemother, vol. 69, no. 11, pp. 3033-40, 2014.
, “Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria”, Clin Infect Dis, vol. 56, no. 5, pp. e48-58, 2013.
, “Malaria in the post-partum period; a prospective cohort study”, PLoS ONE, vol. 8, no. 3, p. e57890, 2013.
, “Micronutrient status in lactating mothers before and after introduction of fortified flour: cross-sectional surveys in Maela refugee camp”, Eur J Nutr, vol. 51, no. 4, pp. 425-34, 2012.
, “Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria”, Antimicrob Agents Chemother, vol. 56, no. 4, pp. 1997-2007, 2012.
, “Pyronaridine-artesunate versus mefloquine plus artesunate for malaria”, N Engl J Med, vol. 366, no. 14, pp. 1298-309, 2012.
, “Refugee and migrant women's views of antenatal ultrasound on the Thai Burmese border: a mixed methods study”, PLoS ONE, vol. 7, no. 4, p. e34018, 2012.
, “Ultrasound evidence of early fetal growth restriction after maternal malaria infection”, PLoS ONE, vol. 7, no. 2, p. e31411, 2012.
, “Barriers to immunization among children of migrant workers from Myanmar living in Tak province, Thailand”, Bull World Health Organ, vol. 89, no. 7, pp. 528-31, 2011.
, “Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand”, Malar J, vol. 10, p. 113, 2011.
, “Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria”, Antimicrob Agents Chemother, vol. 55, no. 9, pp. 4338-42, 2011.
, “A prospective study of urinary pneumococcal antigen detection in healthy Karen mothers with high rates of pneumococcal nasopharyngeal carriage”, BMC Infect Dis, vol. 11, p. 108, 2011.
, “A research agenda for malaria eradication: drugs”, PLoS Med, vol. 8, no. 1, p. e1000402, 2011.
, “First report of an Orientia tsutsugamushi type TA716-related scrub typhus infection in Thailand”, Vector Borne and Zoonotic Diseases, vol. 10, no. 2, pp. 191-3, 2010.
, “Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis”, Malar J, vol. 8, p. 203, 2009.
, “Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria”, Antimicrob Agents Chemother, vol. 53, no. 9, pp. 3837-46, 2009.
, “How much fat is necessary to optimize lumefantrine oral bioavailability?”, Trop Med Int Health, vol. 12, no. 2. pp. 195-200, 2007.
, “A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia”, Trop Med Int Health, vol. 12, no. 2, pp. 251-9, 2007.
, “Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative”, PLoS Med, vol. 3, no. 6, p. e183, 2006.
, “Manslaughter by fake artesunate in Asia--will Africa be next?”, PLoS Med, vol. 3, no. 6, p. e197, 2006.
, “The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria”, Eur J Clin Pharmacol, vol. 62, no. 12, pp. 1021-31, 2006.
, “Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria”, Antimicrob Agents Chemother, vol. 50, no. 7, pp. 2281-5, 2006.
, “Toxic brainstem encephalopathy after artemisinin treatment for breast cancer”, Ann Neurol, vol. 59, no. 4, pp. 725-6, 2006.
, “Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria”, Antimicrob Agents Chemother, vol. 49, no. 4, pp. 1622-5, 2005.
, “Artesunate combinations for treatment of malaria: meta-analysis”, Lancet, vol. 363, no. 9402. pp. 9-17, 2004.
, “Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens”, Trans R Soc Trop Med Hyg, vol. 98, no. 3, pp. 182-92, 2004.
, “Central role of the spleen in malaria parasite clearance”, Journal of Infectious Diseases, vol. 185, no. 10, pp. 1538-41., 2002.
, “The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 96, no. 2, pp. 180-4., 2002.
, “The efficacy of chloroquine for the treatment of acute, uncomplicated, Plasmodium falciparum malaria in Laos”, Ann Trop Med Parasitol, vol. 96, no. 6, pp. 553-7, 2002.
, “Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil”, Clinical Infectious Diseases, vol. 35, no. 12, pp. 1498-504., 2002.
, “Factors contributing to anemia after uncomplicated falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 65, no. 5, pp. 614-22., 2001.
, “Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 95, no. 6, pp. 651-6., 2001.
, “Safety of the insect repellent N,N-diethyl-M-toluamide (DEET) in pregnancy”, American Journal of Tropical Medicine and Hygiene, vol. 65, no. 4, pp. 285-9., 2001.
, “Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 5, pp. 545-8., 2000.
, “A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 62, no. 1, pp. 65-9, 2000.
, “Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria”, Antimicrob Agents Chemother, vol. 44, no. 3, pp. 697-704, 2000.
, “Plasmodium falciparum antimalarial drug susceptibility on the north- western border of Thailand during five years of extensive use of artesunate-mefloquine”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 5, pp. 537-44., 2000.
, “Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 6, pp. 689-93., 2000.
, “Absence of an interaction between artesunate and atovaquone-proguanil”, European Journal of Clinical Pharmacology, vol. 55, no. 6, pp. 469-74, 1999.
, “The effects of mefloquine treatment in pregnancy”, Clinical Infectious Diseases, vol. 28, no. 4, pp. 808-15, 1999.
, “Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 6, pp. 936-42, 1999.
, “Genetic analysis of Plasmodium falciparum infections on the north- western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 6, pp. 587-93, 1999.
, “Meet my uncle”, Lancet, vol. 353, no. 9150, p. 414., 1999.
, “No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine”, American Journal of Tropical Medicine and Hygiene, vol. 61, no. 6, pp. 964-7, 1999.
, “Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria”, Antimicrob Agents Chemother, vol. 43, no. 2, pp. 341-6, 1999.
, “Population pharmacokinetics of mefloquine in patients with acute falciparum malaria”, Clinical Pharmacology and Therapeutics, vol. 66, no. 5, pp. 472-84, 1999.
, “Risk factors for gametocyte carriage in uncomplicated falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 6, pp. 1019-23, 1999.
, “Treatment of vivax malaria on the western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 4, pp. 433-8, 1999.
, “Artemisinin derivatives in the treatment of falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 4, pp. 430-3., 1998.
, “Artesunate and mefloquine in the treatment of uncomplicated multidrug- resistant hyperparasitaemic falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 2, pp. 207-11, 1998.
, “Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 59, no. 6, pp. 883-8, 1998.
, “Intrarectal artemisinin derivatives”, Medecine Tropicale, vol. 58, no. 3, pp. 63-4, 1998.
, “Maternal antibodies block malaria”, NATURE, vol. 395, no. 6705. pp. 851-2, 1998.
, “Quinine and mefloquine in the treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy”, Annals of Tropical Medicine and Parasitology, vol. 92, no. 6, pp. 643-53., 1998.
, “Randomized comparison of artemether-benflumetol and artesunate- mefloquine in treatment of multidrug-resistant falciparum malaria”, Antimicrob Agents Chemother, vol. 42, no. 1, pp. 135-9, 1998.
, “The relationship between capillary and venous concentrations of the antimalarial drug lumefantrine (benflumetol)”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 5, pp. 564-5, 1998.
, “Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 91, no. 5, pp. 574-7, 1997.
, “The epidemiology of severe malaria in an area of low transmission in Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 91, no. 3, pp. 256-62, 1997.
, “Factors affecting the pharmacokinetics of parenteral chloramphenicol in enteric fever”, Journal of Antimicrobial and Chemotherapy, vol. 40, no. 1, pp. 91-8, 1997.
, “Phase I trial of the SPf66 malaria vaccine in a malaria-experienced population in Southeast Asia”, Am J Trop Med Hyg, vol. 56, no. 5, pp. 526-32, 1997.
, “SPf66 malaria vaccine is safe and immunogenic in malaria naive adults in Thailand”, Acta Tropica, vol. 67, no. 3, pp. 215-27, 1997.
, “Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay”, British Journal of Clinical Pharmacology, vol. 42, no. 5, pp. 599-604, 1996.
, “Effects of artemisinin derivatives on malaria transmissibility”, Lancet, vol. 347, pp. 1654-8, 1996.
, “Electrocardiographic monitoring in severe falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 3. pp. 266-9, 1996.
, “The epidemiology of malaria in a Karen population on the western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 2, pp. 105-11, 1996.
, “Mefloquine in infants and young children”, Annals of Tropical Paediatrics, vol. 16, no. 4, pp. 281-6, 1996.
, “Clinical features and outcome of severe malaria in Gambian children”, Clinical Infectious Diseases, vol. 21, no. 3, pp. 577-87, 1995.
, “Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients”, Bulletin of the World Health Organization, vol. 73, no. 5, pp. 631-42, 1995.
, “Non specific resistance against malaria pre-erythrocytic stages: involvement of acute phase proteins”, Parasite, vol. 2, no. 3, pp. 263-8, 1995.
, “Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 53, no. 5, pp. 522-5, 1995.
, “Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 89, no. 6, pp. 660-4, 1995.
, “Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutyl-halofantrine measured by high-performance liquid chromatography”, American Journal of Tropical Medicine and Hygiene, vol. 51, no. 6, pp. 778-84, 1994.
, “Mefloquine prophylaxis prevents malaria during pregnancy: a double- blind, placebo-controlled study”, Journal of Infectious Diseases, vol. 169, no. 3, pp. 595-603, 1994.
, “Single day mefloquine-artesunate combination in the treatment of multi- drug resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 88, no. 2, pp. 213-7, 1994.
, “Treatment of multidrug-resistant Plasmodium falciparum malaria with 3- day artesunate-mefloquine combination”, Journal of Infectious Diseases, vol. 170, no. 4, pp. 971-7, 1994.
, “Bed nets for the prevention of malaria and anaemia in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 87, no. 6. pp. 620-6, 1993.
, “Cardiac effects of antimalarial treatment with halofantrine”, Lancet, vol. 341, pp. 1054-6, 1993.
, “Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria”, Lancet, vol. 341, pp. 1044-9, 1993.
, “High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria”, Journal of Infectious Diseases, vol. 166, no. 6, pp. 1393-400, 1992.
, “Malaria during pregnancy in an area of unstable endemicity”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 85, no. 4, pp. 424-9, 1991.
, “Mefloquine-resistant falciparum malaria on the Thai-Burmese border”, Lancet, vol. 337, no. 8750, pp. 1140-3, 1991.
, “Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine”, Bulletin of the World Health Organization, vol. 65, no. 6. pp. 891-6, 1987.
,